ATE236616T1 - Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten - Google Patents

Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten

Info

Publication number
ATE236616T1
ATE236616T1 AT96933878T AT96933878T ATE236616T1 AT E236616 T1 ATE236616 T1 AT E236616T1 AT 96933878 T AT96933878 T AT 96933878T AT 96933878 T AT96933878 T AT 96933878T AT E236616 T1 ATE236616 T1 AT E236616T1
Authority
AT
Austria
Prior art keywords
sustained release
antagonists
long
administration system
narcotic analgesics
Prior art date
Application number
AT96933878T
Other languages
English (en)
Inventor
Alan Drizen
Peter Rothbart
Gary M Nath
Original Assignee
Lam Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27415224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE236616(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/630,205 external-priority patent/US5716631A/en
Application filed by Lam Pharmaceutical Corp filed Critical Lam Pharmaceutical Corp
Application granted granted Critical
Publication of ATE236616T1 publication Critical patent/ATE236616T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96933878T 1995-09-29 1996-09-25 Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten ATE236616T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53675095A 1995-09-29 1995-09-29
US58827296A 1996-01-18 1996-01-18
US08/630,205 US5716631A (en) 1995-09-29 1996-04-10 Long acting narcotic analgesics and antagonists
PCT/US1996/015293 WO1997011681A1 (en) 1995-09-29 1996-09-25 Sustained release delivery system and long acting narcotic analgesics and antagonists

Publications (1)

Publication Number Publication Date
ATE236616T1 true ATE236616T1 (de) 2003-04-15

Family

ID=27415224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96933878T ATE236616T1 (de) 1995-09-29 1996-09-25 Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten

Country Status (7)

Country Link
EP (1) EP0859597B1 (de)
AT (1) ATE236616T1 (de)
AU (1) AU7244696A (de)
CA (1) CA2233280A1 (de)
DE (1) DE69627365T2 (de)
ES (1) ES2196180T3 (de)
WO (1) WO1997011681A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US6251436B1 (en) * 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form
US20020177626A1 (en) 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
DE10358749A1 (de) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform zur Bekämpfung von primären Kopfschmerzen
WO2013134362A1 (en) * 2012-03-07 2013-09-12 Mallinckrodt Llc Improved stability of hydromorphone hydrochloride solutions
US9155734B2 (en) 2012-03-07 2015-10-13 Mallinckrodt Llc Stability of hydromorphone hydrochloride solutions
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
IT201800001890A1 (it) 2018-01-25 2019-07-25 Fidia Farm Spa Composizioni farmaceutiche per il trattamento del dolore postoperatorio

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
EP0516026A1 (de) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel und Verfahren zu seiner Herstellung
US5356629A (en) * 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair

Also Published As

Publication number Publication date
WO1997011681A1 (en) 1997-04-03
ES2196180T3 (es) 2003-12-16
AU7244696A (en) 1997-04-17
DE69627365T2 (de) 2004-02-12
DE69627365D1 (de) 2003-05-15
EP0859597A1 (de) 1998-08-26
CA2233280A1 (en) 1997-04-03
EP0859597A4 (de) 1998-10-07
EP0859597B1 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
ATE232091T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
ATE236616T1 (de) Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten
FI963025A (fi) Väärinkäytön estävät tabletit
GR960100179A (el) Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα.
DE69019170D1 (de) Vorgeschlitzte Injektionsstelle sowie konische Kanüle.
AU2002322289A1 (en) Biodegradable polymer coompositions
DK288987D0 (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
NO996310L (no) Sammensetninger og fremgangsmÕter for Õ redusere respirasjonsdepresjon og ledsagende bivirkninger av mu-opioide forbindelser
DE69536035D1 (de) Schmelzextrudierte oral verabreichbare Opioidformulierungen
AU5924199A (en) Methods and apparatus for improved administration of fentanyl and sufentanil
DE60108255D1 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
IE870064L (en) Sustained release capsule
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
DE69731882D1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
ES2099048T1 (es) Uso de ropivacaina en la fabricacion de un producto farmaceutico con efectos analgesicos con bloqueo motor minimo.
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
DE60004833D1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
ATE326954T1 (de) Transdermales therapeutisches system zur verabreichung von calciumantagonisten
Livezey et al. Blocking of Morphine Induced Oral Stereotypy by the NMDA Receptor Antagonist MK-801
BRPI0315657B8 (pt) formulação de dosagem sólida, comprimido para liberação controlada, método de fabricar uma medicação de liberação controlada, composição farmacêutica e uso de uma composição
AU1290797A (en) Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties